Skip to search formSkip to main contentSkip to account menu

CS 866

Known as: 866, CS, CS-866 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Olmesartan medoxomilolmesartan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Study on Fermentation Conditions of Cephalosporium sinensis Strain CS-866
The fermentation conditions of the mycelia of Cordyceps sinensis strain CS-866 was studied in this research,the results showed… 
2004
2004
Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury
Increased cardiovascular mortality is an unresolved problem in patients with chronic renal failure. Cardiac hypertrophy is… 
2003
2003
The preferential inhibitory effect of olmesartan, a new angiotensin II type 1 antagonist, on sympathetic nerve terminals in isolated canine splenic artery.
Effects of olmesartan (RNH-6270: (5-methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl[4-[2-(tetrazol-5… 
2002
2002
CS-866, a New Angiotensin II Type 1 Receptor Antagonist, Ameliorates Glomerular Anionic Site Loss and Prevents Progression of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty Rats
BackgroundDiabetic nephropathy is a leading cause of end-stage renal disease in industrialized countries. Previous studies have… 
2002
2002
Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866)
An insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene has been reported to affect the activity of… 
2001
2001
[Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats].
To assess the chronic antihypertensive and renal protective effects of the specific angiotensin II receptor antagonist, CS-866… 
2001
2001
Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
We previously reported that chronic inhibition of nitric oxide (NO) synthesis with N(omega)-nitro-L-arginine methyl ester (L-NAME… 
2001
2001
Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits.
CS-866 is an angiotensin II type-1 receptor antagonist, the effects of which on systolic blood pressure (BP) and glucose/insulin… 
1999
1999
Cilnidipine Improves Insulin Sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Spontaneous NIDDM
Summary. Among the antihypertensive drugs, fast-acting Ca2+ antagonists have been reported to worsen insulin sensitivity. This… 
1998
1998
D035 CS-866 (angiotensin-II receptor antagonist): A double-blind study using ambulatory blood pressure monitoring in hypertensive patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)